To the best of our knowledge, this was the first study to show CpG-ODNs could restore steroid sensitivity and block RORt-induced upregulation of IL-17 in CS-induced asthma in vivo, as well as in CSE-induced HBE cells, possibly through the restoration of HDAC2 levels and activity. This evidence concerns the gene IL17A and asthma.